MARX Biotech Co

MARX Biotech Co EBITDA per Share

The EBITDA per Share of MARX Biotech Co (7731.TWO) as of Oct 19, 2026 is -0.28 TWD. In the previous year, EBITDA per Share was -0.13 TWD — a change of 108.22% (lower).

EBITDA per Share

-0.28TWD

YoY

108.22%

Last updated:

EBITDA per Share of MARX Biotech Co is 2025 -0.28 TWD. EBITDA per Share of MARX Biotech Co was 2024 -0.13 TWD. It decreases by 108.22% lower compared to the previous year.

The MARX Biotech Co EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2021
0.03 TWD
Jan 1, 2022
0.00 TWD
Jan 1, 2023
-0.02 TWD
Jan 1, 2024
-0.13 TWD
Jan 1, 2025
-0.28 TWD
The MARX Biotech Co EBITDA per Share history
YEAREBITDA per ShareYoY
-0.28TWD+108.22%
-0.13TWD+438.98%
-0.02TWD-1,483.81%
0.00TWD-94.03%
0.03TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

MARX Biotech Co Stock analysis

What does MARX Biotech Co do? MARX Biotech Co Ltd is a company based in Taipei, Taiwan, with its headquarters located in New Taipei. The company went public on February 5, 2024, and its stock is listed under the ticker 7731.TWO. It operates within the biotechnology sector, though specific industry details are not provided. MARX Biotech focuses on developing products across multiple categories, including health foods, skincare, hair care, health products, and cleaning products. These products are distributed through domestic brand official sales platforms, e-commerce platforms, chain and small to medium-sized cosmeceutical pharmacies, and overseas cross-border e-commerce channels. The company manages four primary brands: TAIZAKU, a high-end men's health brand; Inyouso, a skincare and healthcare brand; Phargoods, a sports and children's healthcare brand; and SnowIOU, a beauty care brand. The company emphasizes data-driven innovation strategies in its operations. Its website is https://marxbiotech.com/. The company's sector and industry classifications are listed as N/A in available records, indicating a lack of specific categorization within standard financial or industrial frameworks. The company's operations and product range reflect a focus on health and wellness, with an emphasis on both domestic and international markets through various sales channels. MARX Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MARX Biotech Co stock

EBITDA per Share of MARX Biotech Co is -0.28 TWD in 2025.

EBITDA per Share of MARX Biotech Co changed from -0.13 TWD to -0.28 TWD, representing a 108.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share MARX Biotech Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — MARX Biotech Co

All Key Metrics — MARX Biotech Co